Transforming the future of treating the undruggables with AI
DearTRANS
Genome data Analysis
WX
Biomarker Prediction
AI-Powered
DearDTI
Molecule Selection
MolEQ
Lead Optimization
AI-Powered
Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new drugs.
Our Technology Dr.UG
Pipeline
Deargen’s A.I technology is being applied to various new drug development treatment strategies.
PROTAC
ADC
EPITOPE
AGONIST
INHIBITOR
Partners